Charles McKhann
Chief Executive Officer chez SILK ROAD MEDICAL, INC
Fortune : 13 M $ au 31/03/2024
Profil
Charles Serge McKhann currently works at Silk Road Medical, Inc., as Chief Executive Officer & Director from 2023.
Mr. McKhann also formerly worked at Apnex Medical, Inc., as President & Chief Executive Officer from 2010 to 2011, Apollo Endosurgery, Inc., as President, Chief Executive Officer & Director from 2021 to 2023, Vernon Consulting, Inc., as Managing Director from 2012 to 2021, ROX Medical, Inc., as Chief Commercial Officer from 2017 to 2018, Torax Medical, Inc., as Chief Commercial Officer from 2016 to 2017, and Intersect ENT, Inc., as Chief Commercial Officer from 2015 to 2016.
Mr. McKhann received his undergraduate degree in 1991 from Stanford University and Masters Business Admin degree in 1998 from Stanford University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SILK ROAD MEDICAL, INC.
1,84% | 01/03/2024 | 722 396 ( 1,84% ) | 13 M $ | 31/03/2024 |
Postes actifs de Charles McKhann
| Sociétés | Poste | Début |
|---|---|---|
| SILK ROAD MEDICAL, INC | Chief Executive Officer | 02/11/2023 |
Anciens postes connus de Charles McKhann
| Sociétés | Poste | Fin |
|---|---|---|
| APOLLO ENDOSURGERY, INC. | Chief Executive Officer | 04/04/2023 |
| Vernon Consulting, Inc. | Chief Executive Officer | 01/03/2021 |
ROX Medical, Inc.
 ROX Medical, Inc. Medical SpecialtiesHealth Technology ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA. | Corporate Officer/Principal | 01/11/2018 |
Torax Medical, Inc.
 Torax Medical, Inc. Medical SpecialtiesHealth Technology Torax Medical Inc. designs and develops medical devices to treat chronic diseases related to defective sphincter muscles. Its technology platform, Magnetic Sphincter Augmentation (MSA), uses attraction forces to augment weak or defective sphincter muscles to treat gastroesophageal reflux disease (GERD) and fecal incontinence (FI). The firm's products include LINX, a reflux management system for the treatment of GERD; and FENIX, a continence restoration system for the treatment of FI. The company was founded by Todd Berg in 2002 and is headquartered in Shoreview, MN. | Corporate Officer/Principal | 01/04/2017 |
| INTERSECT ENT, INC. | Corporate Officer/Principal | 15/07/2016 |
Formation de Charles McKhann
| Stanford University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SILK ROAD MEDICAL, INC | Health Technology |
| Entreprise privées | 6 |
|---|---|
ROX Medical, Inc.
ROX Medical, Inc. Medical SpecialtiesHealth Technology ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA. | Health Technology |
Torax Medical, Inc.
Torax Medical, Inc. Medical SpecialtiesHealth Technology Torax Medical Inc. designs and develops medical devices to treat chronic diseases related to defective sphincter muscles. Its technology platform, Magnetic Sphincter Augmentation (MSA), uses attraction forces to augment weak or defective sphincter muscles to treat gastroesophageal reflux disease (GERD) and fecal incontinence (FI). The firm's products include LINX, a reflux management system for the treatment of GERD; and FENIX, a continence restoration system for the treatment of FI. The company was founded by Todd Berg in 2002 and is headquartered in Shoreview, MN. | Health Technology |
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
Apnex Medical, Inc.
 Apnex Medical, Inc. Medical SpecialtiesHealth Technology Apnex Medical, Inc. manufactured medical devices. It developed a proprietary active implantable medical device for the treatment of obstructive sleep apnea (OSA). The company was founded by Chad J. Kugler, Michael L. Berman and Robert E. Atkinson in 2006 and was headquartered in St. Paul, MN. | Health Technology |
Apollo Endosurgery, Inc.
 Apollo Endosurgery, Inc. Medical SpecialtiesHealth Technology Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX. | Health Technology |
| Vernon Consulting, Inc. |
